vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
33.28
-0.43 (-1.28%)
Mar 13, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Biotechnology (Startups)
2.02M4.01M6.41M2.76M12.43M
Biotechnology (Startups) Growth
-49.61%-37.56%132.05%-77.77%4172.85%
Total
2.02M4.01M6.41M2.76M12.43M
Total Growth
-49.61%-37.56%132.05%-77.77%4172.85%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
-4.01M6.41M2.76M12.43M
United States Growth
--37.56%132.05%-77.77%4172.85%
China
2.00M----
Total
2.00M4.01M6.41M2.76M12.43M
Total Growth
-50.06%-37.56%132.05%-77.77%4172.85%
Source: S&P Global Market Intelligence.